Clinical Neurology NewsFDA approves safinamide to treat Parkinson’s diseaseMarch 22, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsOnline Algorithm Identifies People at Risk of Parkinson’s DiseaseMarch 6, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsWhich Cognitive Domains Predict Progression From MCI to Dementia in Parkinson’s Disease?March 6, 2017Parkinson's DiseaseMovement DisordersAlzheimer's & Cognition
Neurology ReviewsSublingual Apomorphine Film May Induce On State in Patients With Parkinson’s Disease March 6, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsMCI May Predict Dementia in Patients With Parkinson’s DiseaseMarch 3, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsBlood NfL Accurately Differentiates Parkinson’s Disease From Atypical Parkinsonian DisordersMarch 3, 2017Parkinson's Disease
Neurology ReviewsIs Closed-Loop DBS Ready for Clinical Application?March 3, 2017Movement DisordersParkinson's Disease
Clinical Neurology NewsLight therapy eases Parkinson’s-related sleep disturbancesFebruary 21, 2017Parkinson's DiseaseSleep MedicineMovement Disorders
Neurology ReviewsWhat Are the Best Treatments for Nonmotor Symptoms in Parkinson’s Disease?January 31, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsPatient Expectations May Be Potent Factor in DBS for Parkinson’s DiseaseJanuary 30, 2017Parkinson's DiseaseMovement Disorders
Neurology ReviewsGene Mutation Linked to Early Onset of Parkinson’s DiseaseDecember 28, 2016Parkinson's DiseaseMovement Disorders
Neurology ReviewsTreatment Advances in Parkinson’s Disease and Other Movement DisordersDecember 27, 2016Parkinson's DiseaseMovement Disorders
Neurology ReviewsDBS and Optimal Therapy May Have Long-Term Benefit in Early Parkinson’s DiseaseNovember 28, 2016Parkinson's DiseaseMovement Disorders
Neurology ReviewsPINK1 Mutation Raises Risk of Early-Onset Parkinson’s DiseaseNovember 28, 2016Parkinson's Disease